Across TCGA pan-cancer cohorts, RPL13P12 RNA is linked to patient survival in 25 of 34 cancer types, making it the most broadly survival-associated RPL13P12 data layer.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher RPL13P12 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RPL13P12 expression acts as an unfavorable survival marker, although some lineages such as BRCA and CESC show a favorable association.

ACC, LUAD, and BRCA are the cancer types where RPL13P12 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	OS	Median	II,III,IV	0.750	0.945	<.001	82	view →
LUAD	OS	Median	All	0.773	0.849	.007	47	view →
BRCA	OS	Tertile	IV	0.789	0.329	.002	38	view →
CESC	DFS	Tertile	III,IV	0.725	0.225	.005	26	view →
KIRC	DFS	Median	IV	0.625	0.394	.015	26	view →
THYM	DFS	Tertile	All	0.951	0.470	.005	18	view →
PRAD	DFS	Median	All	0.846	0.919	.008	18	view →
MESO	OS	Median	IV	0.819	0.282	<.001	17	view →
STAD	OS	Quartile	III,IV	0.736	0.301	.021	12	view →
UVM	DFS	Median	III,IV	0.322	0.868	.015	12	view →
COAD	DFS	Quartile	II,III,IV	0.834	0.540	<.001	12	view →
PCPG	DFS	Tertile	All	0.954	0.663	.007	11	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 25 lineages.

Exploration

Same gene, other analysis: RPL13P12 tumor-vs-normal RNA expression · all RPL13P12 data types